INSIGHTS ON SOLID DOSE MANUFACTURING

• 6 Strategic Pillars For Selecting A Drug Packaging Partner

  Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.

• How Dosage Form Decisions Shape Pediatric And Geriatric Drug Development

  Developing pediatric and geriatric pharmaceuticals requires customized strategies beyond tablet crushing, balancing specific age-related palatability, packaging, real-world administration, and lifecycle management needs for optimal patient outcomes.

• Predicting Drug-Loading Limits In Tablet Formulations

  Learn how predictive percolation modeling identified critical drug-loading limits of ~20% for crystalline API and ~15% for SDD forms, cutting tablet formulation trial-and-error significantly.

• Adapting To Evolving Needs: How Modular Cleanrooms Enhance Safety In Pharmaceutical Manufacturing

  High-potency therapies demand stringent containment and worker safety. Discover how scalable, modular infrastructure simplifies compliance and protects product integrity in regulated facilities.

• Developing And Manufacturing Minitablets To Extend Drug Lifecycle

  1/27/2025

  Pharmaceutical companies should leverage oral minitablets to extend drug lifecycles, optimize dosing, and improve patient-centric solutions while overcoming manufacturing challenges.

• Maximum Protection With Superior Quality

  9/2/2026

  See how this automated capsule filling technology integrates high-containment isolators and 100% inline checkweighing to ensure precise dosing, operator safety, and continuous quality control

• Delivering API-In-Capsule For Potent, Low-Flow Compounds

  9/9/2026

  See how an automated capsule-filling approach addressed poor-flow APIs, improved operator safety, and supported fast scale-up for clinical supply needs.

• When To Consider Material And Personnel Airlocks For Downflow Booths

  3/20/2026

  Strategic use of airlocks in downflow booth design enhances pressure stability and containment. A risk-based approach ensures facility integration meets rigorous safety and compliance standards.

• Practical Formulation Strategies For Poorly Soluble APIs

  10/2/2026

  Poor aqueous solubility now defines most drug candidates in development, making early screening and solid-state assessment essential to achieving reliable exposure and avoiding costly reformulation downstream.